Find the CANCER BUZZ podcast on Apple Podcasts, Spotify, or wherever you get your podcasts!
As the number of patients and survivors of cancer grows each year, awareness of the disease’s emotional toll—including depression, anxiety, and deep existential distress—is increasingly recognized as a critical aspect of cancer care. In response, psychedelic-assisted therapy is gaining attention as a promising alternative to traditional mental health interventions, providing relief for some patients. To shed light on the patient experience with this treatment, CANCER BUZZ spoke with breast cancer survivor Judy Wight; Jennifer Bires, MSW, LCSW, OSW-C, FACCC, executive director of Life with Cancer and Patient Experience at Inova Health System; and Manish Agrawal, MD, cofounder and CEO of Sunstone Therapies, about the human side of psychedelic-assisted therapy, promising existing research, and how it can shape the future of psychosocial care.
“It’s not that I’m a different person. It’s more like I’m becoming the person I was meant to be. And all those layers of trauma and sadness...I’ve been able to shed a lot of that.” – Judy Wight
“When I started to learn about psychedelic-assisted therapy, read some of the patient accounts, and see some of the research, I said, ‘I've got to learn about this. I think that this could be another tool that would be useful for people in this space where we don't have the perfect answer, and we don't have the perfect treatments.’” – Jennifer Bires, MSW, LCSW, OSW-C, FACCC
“When I give talks around this, I have an iceberg. Above the iceberg I have chemotherapy, surgery, and radiation, and underneath the iceberg I have what’s called psychosocial, psycho-spiritual, psychological care. And I think true cancer care is treating everything in the iceberg, not just what's above the water.” – Manish Agrawal, MD
Guests:
Jennifer Bires, MSW, LCSW, OSW-C, FACCC
Executive Director, Life with Cancer and Patient Experience
Inova Health System
Fairfax, VA
Judy Wight
Breast Cancer Survivor
Manish Agrawal,MD
Cofounder andCEO
Sunstone Therapies
REKINDLE Investigator
This podcast is sponsored by Reunion Neuroscience.
Scan to learn more about the REKINDLE study:
The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Cancer Care Centers.
July 8, 2026
June 30, 2026
At the 2026 ASCO Annual Meeting, the Louisiana Oncology Society received the ASCO Jeffrey C Ward Affiliate Advocacy Award for advancing critical advocacy priorities that have translated into meaningful legislative victories. The Iowa Oncology Society and Washington State Medical Oncology Society were also recognized for their advocacy efforts in 2025 at the meeting, receiving second place awards.
